annual EBITDA:
$117.28M+$14.92M(+14.57%)Summary
- As of today (September 3, 2025), ASTH annual EBITDA is $117.28 million, with the most recent change of +$14.92 million (+14.57%) on December 31, 2024.
- During the last 3 years, ASTH annual EBITDA has risen by +$1.58 million (+1.37%).
- ASTH annual EBITDA is now -3.72% below its all-time high of $121.81 million, reached on December 31, 2022.
Performance
ASTH EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
$27.24M-$188.00K(-0.69%)Summary
- As of today (September 3, 2025), ASTH quarterly EBITDA is $27.24 million, with the most recent change of -$188.00 thousand (-0.69%) on June 30, 2025.
- Over the past year, ASTH quarterly EBITDA has dropped by -$10.26 million (-27.36%).
- ASTH quarterly EBITDA is now -60.47% below its all-time high of $68.93 million, reached on December 1, 2017.
Performance
ASTH quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
$99.21M-$10.26M(-9.37%)Summary
- As of today (September 3, 2025), ASTH TTM EBITDA is $99.21 million, with the most recent change of -$10.26 million (-9.37%) on June 30, 2025.
- Over the past year, ASTH TTM EBITDA has dropped by -$17.95 million (-15.32%).
- ASTH TTM EBITDA is now -41.70% below its all-time high of $170.18 million, reached on September 1, 2018.
Performance
ASTH TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
ASTH EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +14.6% | -27.4% | -15.3% |
| 3 y3 years | +1.4% | +38.1% | -13.6% |
| 5 y5 years | +122.6% | +55.4% | +17.6% |
ASTH EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -3.7% | +14.6% | -50.3% | +2539.9% | -23.4% | at low |
| 5 y | 5-year | -3.7% | +122.6% | -52.9% | +2539.9% | -28.8% | +17.6% |
| alltime | all time | -3.7% | +1982.2% | -60.5% | +672.0% | -41.7% | +908.2% |
ASTH EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $27.24M(-0.7%) | $99.21M(-9.4%) |
| Mar 2025 | - | $27.43M(+210.1%) | $109.47M(-6.7%) |
| Dec 2024 | $117.28M(+14.6%) | $8.85M(-75.2%) | $117.28M(+7.1%) |
| Sep 2024 | - | $35.69M(-4.8%) | $109.46M(-6.6%) |
| Jun 2024 | - | $37.51M(+6.4%) | $117.16M(+5.6%) |
| Mar 2024 | - | $35.23M(+3314.2%) | $110.93M(+8.4%) |
| Dec 2023 | $102.36M(-16.0%) | $1.03M(-97.6%) | $102.36M(-13.2%) |
| Sep 2023 | - | $43.39M(+38.7%) | $117.97M(-8.9%) |
| Jun 2023 | - | $31.28M(+17.3%) | $129.43M(+9.8%) |
| Mar 2023 | - | $26.66M(+60.2%) | $117.89M(-3.2%) |
| Dec 2022 | $121.81M(+5.3%) | - | - |
| Dec 2022 | - | $16.64M(-69.7%) | $121.81M(+8.9%) |
| Sep 2022 | - | $54.84M(+177.9%) | $111.82M(-2.6%) |
| Jun 2022 | - | $19.73M(-35.5%) | $114.81M(-4.6%) |
| Mar 2022 | - | $30.59M(+359.2%) | $120.30M(+4.0%) |
| Dec 2021 | $115.70M(+17.0%) | $6.66M(-88.5%) | $115.69M(-16.9%) |
| Sep 2021 | - | $57.83M(+129.3%) | $139.25M(+12.8%) |
| Jun 2021 | - | $25.23M(-2.9%) | $123.45M(+6.6%) |
| Mar 2021 | - | $25.98M(-14.0%) | $115.76M(+16.7%) |
| Dec 2020 | $98.85M(+87.6%) | $30.22M(-28.1%) | $99.16M(+17.5%) |
| Sep 2020 | - | $42.03M(+139.7%) | $84.36M(+42.2%) |
| Jun 2020 | - | $17.53M(+87.0%) | $59.31M(-2.7%) |
| Mar 2020 | - | $9.38M(-39.2%) | $60.96M(+15.7%) |
| Dec 2019 | $52.69M(-52.8%) | $15.42M(-9.2%) | $52.69M(+10.8%) |
| Sep 2019 | - | $16.98M(-11.5%) | $47.56M(-48.3%) |
| Jun 2019 | - | $19.18M(+1628.7%) | $92.00M(+8.4%) |
| Mar 2019 | - | $1.11M(-89.2%) | $84.88M(-23.9%) |
| Dec 2018 | $111.53M(+96.9%) | $10.29M(-83.3%) | $111.53M(-34.5%) |
| Sep 2018 | - | $61.42M(+409.0%) | $170.18M(+62.4%) |
| Jun 2018 | - | $12.07M(-56.5%) | $104.80M(+17.5%) |
| Mar 2018 | - | $27.76M(-59.7%) | $89.18M(+57.4%) |
| Dec 2017 | $56.65M(-1009.3%) | $68.93M(-1841.0%) | $56.65M(-561.5%) |
| Sep 2017 | - | -$3.96M(+11.4%) | -$12.27M(+47.6%) |
| Jun 2017 | - | -$3.55M(-25.4%) | -$8.32M(+74.6%) |
| Mar 2017 | - | -$4.76M(+30.0%) | -$4.76M(-31.1%) |
| Mar 2016 | -$6.23M(+8446.9%) | -$3.66M(+178.9%) | -$6.91M(+115.1%) |
| Dec 2015 | - | -$1.31M(+292.0%) | -$3.21M(+3.3%) |
| Sep 2015 | - | -$335.20K(-79.1%) | -$3.11M(+417.7%) |
| Jun 2015 | - | -$1.60M(-4584.6%) | -$601.10K(+243.9%) |
| Mar 2015 | -$72.90K(-98.1%) | $35.70K(-102.9%) | -$174.80K(-17.0%) |
| Dec 2014 | - | -$1.21M(-155.7%) | -$210.50K(+8320.0%) |
| Sep 2014 | - | $2.18M(-285.2%) | -$2500.00(-99.9%) |
| Jun 2014 | - | -$1.17M(+17.1%) | -$2.98M(-22.9%) |
| Jan 2014 | -$3.86M(+87.6%) | -$1.00M(+25.9%) | -$3.86M(+14.4%) |
| Oct 2013 | - | -$797.00K(-41.1%) | -$3.38M(-15.8%) |
| Jul 2013 | - | -$1.35M(+92.0%) | -$4.01M(+47.7%) |
| Apr 2013 | - | -$705.30K(+35.9%) | -$2.71M(+31.9%) |
| Jan 2013 | -$2.06M(>+9900.0%) | -$519.00K(-63.8%) | -$2.06M(+14.0%) |
| Oct 2012 | - | -$1.43M(+2365.1%) | -$1.81M(+642.4%) |
| Jul 2012 | - | -$58.10K(+20.0%) | -$243.20K(-29.0%) |
| Apr 2012 | - | -$48.40K(-81.9%) | -$342.60K(-28.4%) |
| Jan 2012 | -$1100.00 | -$266.80K(-305.1%) | -$478.40K(+114.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Oct 2011 | - | $130.10K(-182.6%) | -$222.80K(-37.0%) |
| Jul 2011 | - | -$157.50K(-14.5%) | -$353.90K(+67.0%) |
| Apr 2011 | - | -$184.20K(+1544.6%) | -$211.90K(-1485.0%) |
| Jan 2011 | $15.20K(-122.8%) | -$11.20K(+1020.0%) | $15.30K(-135.7%) |
| Oct 2010 | - | -$1000.00(-93.5%) | -$42.80K(+118.4%) |
| Jul 2010 | - | -$15.50K(-136.0%) | -$19.60K(-129.2%) |
| Apr 2010 | - | $43.00K(-162.0%) | $67.10K(-200.4%) |
| Jan 2010 | -$66.80K(-87.6%) | -$69.30K(-412.2%) | -$66.80K(-33.5%) |
| Oct 2009 | - | $22.20K(-68.8%) | -$100.50K(-75.5%) |
| Jul 2009 | - | $71.20K(-178.3%) | -$410.30K(-29.4%) |
| Apr 2009 | - | -$90.90K(-11.7%) | -$581.30K(+16.7%) |
| Jan 2009 | -$537.70K(+1680.5%) | -$103.00K(-64.2%) | -$498.30K(+25.0%) |
| Oct 2008 | - | -$287.60K(+188.2%) | -$398.70K(+240.2%) |
| Jul 2008 | - | -$99.80K(+1163.3%) | -$117.20K(+343.9%) |
| Apr 2008 | - | -$7900.00(+132.4%) | -$26.40K(-12.6%) |
| Dec 2007 | -$30.20K(+29.1%) | -$3400.00(-44.3%) | -$30.20K(-13.2%) |
| Sep 2007 | - | -$6100.00(-32.2%) | -$34.80K(-3.1%) |
| Jun 2007 | - | -$9000.00(-23.1%) | -$35.90K(+4.4%) |
| Mar 2007 | - | -$11.70K(+46.3%) | -$34.40K(+25.1%) |
| Dec 2006 | -$23.40K(+75.9%) | -$8000.00(+11.1%) | -$27.50K(+20.6%) |
| Sep 2006 | - | -$7200.00(-4.0%) | -$22.80K(+14.6%) |
| Jun 2006 | - | -$7500.00(+56.3%) | -$19.90K(+31.8%) |
| Mar 2006 | - | -$4800.00(+45.5%) | -$15.10K(+12.7%) |
| Dec 2005 | -$13.30K(+31.7%) | -$3300.00(-23.3%) | -$13.40K(+20.7%) |
| Sep 2005 | - | -$4300.00(+59.3%) | -$11.10K(+23.3%) |
| Jun 2005 | - | -$2700.00(-12.9%) | -$9000.00(-19.6%) |
| Mar 2005 | - | -$3100.00(+210.0%) | -$11.20K(+9.8%) |
| Dec 2004 | -$10.10K(+29.5%) | -$1000.00(-54.5%) | -$10.20K(+10.9%) |
| Sep 2004 | - | -$2200.00(-55.1%) | -$9200.00(+10.8%) |
| Jun 2004 | - | -$4900.00(+133.3%) | -$8300.00(+36.1%) |
| Mar 2004 | - | -$2100.00(+61.5%) | -$6100.00(-1.6%) |
| Dec 2003 | -$7800.00(-1.3%) | - | - |
| Sep 2003 | - | -$1300.00(-51.9%) | -$6200.00(+1.6%) |
| Jun 2003 | - | -$2700.00(+22.7%) | -$6100.00(+29.8%) |
| Mar 2003 | - | -$2200.00(+83.3%) | -$4700.00(-17.5%) |
| Dec 2002 | -$7900.00(+58.0%) | - | - |
| Sep 2002 | - | -$1200.00(-7.7%) | -$5700.00(-1.7%) |
| Jun 2002 | - | -$1300.00(-35.0%) | -$5800.00(+11.5%) |
| Mar 2002 | - | -$2000.00(+66.7%) | -$5200.00(+6.1%) |
| Dec 2001 | -$5000.00(-7.4%) | -$1200.00(-7.7%) | -$4900.00(+32.4%) |
| Sep 2001 | - | -$1300.00(+85.7%) | -$3700.00(-7.5%) |
| Jun 2001 | - | -$700.00(-58.8%) | -$4000.00(-9.1%) |
| Mar 2001 | - | -$1700.00(+6.3%) | -$4400.00(-49.4%) |
| Dec 2000 | -$5400.00(-41.9%) | - | - |
| Sep 2000 | - | -$1600.00(+45.5%) | -$8700.00(+7.4%) |
| Jun 2000 | - | -$1100.00(-31.3%) | -$8100.00(+2.5%) |
| Mar 2000 | - | -$1600.00(-63.6%) | -$7900.00(+25.4%) |
| Dec 1999 | -$9300.00(+1062.5%) | -$4400.00(+340.0%) | -$6300.00(+231.6%) |
| Sep 1999 | - | -$1000.00(+11.1%) | -$1900.00(+111.1%) |
| Jun 1999 | - | -$900.00 | -$900.00 |
| Dec 1998 | -$800.00(-42.9%) | - | - |
| Dec 1997 | -$1400.00 | - | - |
FAQ
- What is Astrana Health, Inc. annual EBITDA?
- What is the all time high annual EBITDA for Astrana Health, Inc.?
- What is Astrana Health, Inc. annual EBITDA year-on-year change?
- What is Astrana Health, Inc. quarterly EBITDA?
- What is the all time high quarterly EBITDA for Astrana Health, Inc.?
- What is Astrana Health, Inc. quarterly EBITDA year-on-year change?
- What is Astrana Health, Inc. TTM EBITDA?
- What is the all time high TTM EBITDA for Astrana Health, Inc.?
- What is Astrana Health, Inc. TTM EBITDA year-on-year change?
What is Astrana Health, Inc. annual EBITDA?
The current annual EBITDA of ASTH is $117.28M
What is the all time high annual EBITDA for Astrana Health, Inc.?
Astrana Health, Inc. all-time high annual EBITDA is $121.81M
What is Astrana Health, Inc. annual EBITDA year-on-year change?
Over the past year, ASTH annual EBITDA has changed by +$14.92M (+14.57%)
What is Astrana Health, Inc. quarterly EBITDA?
The current quarterly EBITDA of ASTH is $27.24M
What is the all time high quarterly EBITDA for Astrana Health, Inc.?
Astrana Health, Inc. all-time high quarterly EBITDA is $68.93M
What is Astrana Health, Inc. quarterly EBITDA year-on-year change?
Over the past year, ASTH quarterly EBITDA has changed by -$10.26M (-27.36%)
What is Astrana Health, Inc. TTM EBITDA?
The current TTM EBITDA of ASTH is $99.21M
What is the all time high TTM EBITDA for Astrana Health, Inc.?
Astrana Health, Inc. all-time high TTM EBITDA is $170.18M
What is Astrana Health, Inc. TTM EBITDA year-on-year change?
Over the past year, ASTH TTM EBITDA has changed by -$17.95M (-15.32%)